• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终末产物受体的晚期糖基化终末产物配体:生化特性及形成动力学

Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.

作者信息

Valencia Jessica V, Weldon Stephen C, Quinn Douglas, Kiers Geesje H, DeGroot Jeroen, TeKoppele Johan M, Hughes Thomas E

机构信息

Novartis Institutes for BioMedical Research, 100 Technology Square, Bldg. 601/Rm. 5155, Cambridge, MA 02139, USA.

出版信息

Anal Biochem. 2004 Jan 1;324(1):68-78. doi: 10.1016/j.ab.2003.09.013.

DOI:10.1016/j.ab.2003.09.013
PMID:14654047
Abstract

Advanced glycation end products (AGEs) accumulate with age and at an accelerated rate in diabetes. AGEs bind cell-surface receptors including the receptor for advanced glycation end products (RAGE). The dependence of RAGE binding on specific biochemical characteristics of AGEs is currently unknown. Using standardized procedures and a variety of AGE measures, the present study aimed to characterize the AGEs that bind to RAGE and their formation kinetics in vitro. To produce AGEs with varying RAGE binding affinity, bovine serum albumin (BSA) AGEs were prepared with 0.5M glucose, fructose, or ribose at times of incubation from 0 to 12 weeks or for up to 3 days with glycolaldehyde or glyoxylic acid. The AGE-BSAs were characterized for RAGE binding affinity, fluorescence, absorbance, carbonyl content, reactive free amine content, molecular weight, pentosidine content, and N-epsilon-carboxymethyl lysine content. Ribose-AGEs bound RAGE with high affinity within 1 week of incubation in contrast to glucose- and fructose-AGE, which required 12 and 6 weeks, respectively, to generate equivalent RAGE ligands (IC50=0.66, 0.93, and 1.7 microM, respectively). Over time, all of the measured AGE characteristics increased. However, only free amine content robustly correlated with RAGE binding affinity. In addition, detailed protocols for the generation of AGEs that reproducibly bind RAGE with high affinity were developed, which will allow for further study of the RAGE-AGE interaction.

摘要

晚期糖基化终末产物(AGEs)会随着年龄增长而累积,在糖尿病患者中其累积速度会加快。AGEs可与包括晚期糖基化终末产物受体(RAGE)在内的细胞表面受体结合。目前尚不清楚RAGE结合对AGEs特定生化特性的依赖性。本研究采用标准化程序和多种AGE测量方法,旨在体外表征与RAGE结合的AGEs及其形成动力学。为了制备具有不同RAGE结合亲和力的AGEs,用0.5M葡萄糖、果糖或核糖在0至12周的孵育时间内或用乙醇醛或乙醛酸孵育长达3天来制备牛血清白蛋白(BSA)AGEs。对AGE-BSAs进行RAGE结合亲和力、荧光、吸光度、羰基含量、反应性游离胺含量、分子量、戊糖苷含量和N-ε-羧甲基赖氨酸含量的表征。与葡萄糖-AGEs和果糖-AGEs相比,核糖-AGEs在孵育1周内就能以高亲和力结合RAGE,而葡萄糖-AGEs和果糖-AGEs分别需要12周和6周才能产生等效的RAGE配体(IC50分别为0.66、0.93和1.7 microM)。随着时间的推移,所有测量的AGE特性均增加。然而,只有游离胺含量与RAGE结合亲和力密切相关。此外,还制定了可重复产生与RAGE高亲和力结合的AGEs的详细方案,这将有助于进一步研究RAGE-AGE相互作用。

相似文献

1
Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.晚期糖基化终末产物受体的晚期糖基化终末产物配体:生化特性及形成动力学
Anal Biochem. 2004 Jan 1;324(1):68-78. doi: 10.1016/j.ab.2003.09.013.
2
Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.晚期糖基化终末产物(RAGE)配体的受体结合不足以诱导炎症信号:无内毒素白蛋白衍生的晚期糖基化终末产物缺乏活性。
Diabetologia. 2004 May;47(5):844-52. doi: 10.1007/s00125-004-1392-9. Epub 2004 May 1.
3
Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor.乙醇醛是晚期糖基化终末产物的一种反应性中间体,在生成巨噬细胞清道夫受体的活性配体过程中发挥重要作用。
Diabetes. 2000 Oct;49(10):1714-23. doi: 10.2337/diabetes.49.10.1714.
4
The biology of the receptor for advanced glycation end products and its ligands.晚期糖基化终末产物受体及其配体的生物学特性
Biochim Biophys Acta. 2000 Dec 20;1498(2-3):99-111. doi: 10.1016/s0167-4889(00)00087-2.
5
N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.N-ε-(羧甲基)赖氨酸是组织蛋白中主要的晚期糖基化终末产物(AGE)抗原。
Biochemistry. 1995 Aug 29;34(34):10872-8. doi: 10.1021/bi00034a021.
6
Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. Competition with advanced glycation end product-modified serum albumin at the advanced glycation end product receptor.甲基乙二醛修饰的血清白蛋白的受体介导内吞摄取。在晚期糖基化终产物受体处与晚期糖基化终产物修饰的血清白蛋白竞争。
J Biol Chem. 1994 Dec 23;269(51):32293-8.
7
Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.果糖通过激活晚期糖基化终产物-受体系统引起内皮细胞损伤。
Diab Vasc Dis Res. 2019 Nov;16(6):556-561. doi: 10.1177/1479164119866390. Epub 2019 Aug 2.
8
Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.晚期糖基化终末产物及其细胞受体RAGE在糖尿病肾病和非糖尿病性肾脏疾病中的表达
J Am Soc Nephrol. 2000 Sep;11(9):1656-1666. doi: 10.1681/ASN.V1191656.
9
Identification of a novel advanced glycation end product derived from lactaldehyde.一种源自乳醛的新型晚期糖基化终产物的鉴定。
Biosci Biotechnol Biochem. 2019 Jun;83(6):1136-1145. doi: 10.1080/09168451.2019.1585745. Epub 2019 Mar 1.
10
Microplate-based Assay for Screening of Advanced Glycation End Products Binding to Its Receptor.基于微孔板的晚期糖基化终产物与其受体结合的筛选测定法。
Anal Sci. 2019 Mar 10;35(3):237-240. doi: 10.2116/analsci.18C021. Epub 2019 Jan 11.

引用本文的文献

1
Network pharmacology-based study in polymetformin's new function of blocking ages/rage pathway curing diabetic complications.基于网络药理学的研究:二甲双胍阻断晚期糖基化终末产物/晚期糖基化终末产物受体(AGES/RAGE)通路治疗糖尿病并发症的新功能
Sci Rep. 2025 Jun 4;15(1):19632. doi: 10.1038/s41598-025-00956-w.
2
The association between diabetes mellitus and musculoskeletal disorders: a systematic review and meta-analysis.糖尿病与肌肉骨骼疾病的关联:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2024 Apr 3;15:1320468. doi: 10.3389/fendo.2024.1320468. eCollection 2024.
3
Non-apoptotic programmed cell deaths in diabetic pulmonary dysfunction: the new side of advanced glycation end products.
糖尿病性肺功能障碍中的非凋亡程序性细胞死亡:晚期糖基化终产物的新作用。
Front Endocrinol (Lausanne). 2023 Oct 26;14:1126661. doi: 10.3389/fendo.2023.1126661. eCollection 2023.
4
Bone morphogenetic protein-7 attenuates pancreatic damage under diabetic conditions and prevents progression to diabetic nephropathy via inhibition of ferroptosis.骨形态发生蛋白 7 通过抑制铁死亡减轻糖尿病状态下的胰腺损伤并防止其进展为糖尿病肾病。
Front Endocrinol (Lausanne). 2023 May 24;14:1172199. doi: 10.3389/fendo.2023.1172199. eCollection 2023.
5
Musculoskeletal complications in patients with diabetes mellitus.糖尿病患者的肌肉骨骼并发症。
Korean J Intern Med. 2022 Nov;37(6):1099-1110. doi: 10.3904/kjim.2022.168. Epub 2022 Oct 27.
6
Impact of elevated serum advanced glycation end products and exercise on intact and injured murine tendons.血清晚期糖基化终产物升高和运动对完整和受损的鼠肌腱的影响。
Connect Tissue Res. 2023 Mar;64(2):161-174. doi: 10.1080/03008207.2022.2135508. Epub 2022 Oct 25.
7
Descriptive transcriptome analysis of tendon derived fibroblasts following in-vitro exposure to advanced glycation end products.肌腱衍生成纤维细胞在体外接触晚期糖基化终产物后的描述性转录组分析。
PLoS One. 2022 Jul 26;17(7):e0271770. doi: 10.1371/journal.pone.0271770. eCollection 2022.
8
How Diabetes and Other Comorbidities of Elderly Patients and Their Treatment Influence Levels of Glycation Products.如何影响糖化产物水平的老年患者及其合并症和治疗。
Int J Environ Res Public Health. 2022 Jun 20;19(12):7524. doi: 10.3390/ijerph19127524.
9
Dysregulated Erythroid Mg Efflux in Type 2 Diabetes.2型糖尿病中红细胞镁外流失调
Front Cell Dev Biol. 2022 Apr 4;10:861644. doi: 10.3389/fcell.2022.861644. eCollection 2022.
10
Revisiting Methodologies for In Vitro Preparations of Advanced Glycation End Products.重新审视用于体外制备晚期糖基化终产物的方法学。
Appl Biochem Biotechnol. 2022 Jun;194(6):2831-2855. doi: 10.1007/s12010-022-03860-5. Epub 2022 Mar 8.